Acetylcholine Receptor Antibody Positivity, RNST Abnormality, and Thymoma Predict Generalization in Ocular Myasthenia Gravis: A South Korean Cohort Study
Antibodies · 11.08.2026 · 15 (4) · 73
DOI: 10.3390/antib15040073 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Antibodies, online erschienen am 11.08.2026. Verfasst von Hyun Jin Shin und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Konkuk University, Chungju-si 27478, Republic of Korea. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Background
Ocular myasthenia gravis (OMG) can remain restricted to ocular symptoms or progress to generalized myasthenia gravis (GMG). However, the rate of generalization and its predictors may vary across populations, and data on South Korean patients remain inadequate. This study investigated the conversion rate from OMG to GMG and identified clinical, serologic, electrophysiologic, and thymic predictors of this generalization in a South Korean cohort.
Methods
This retrospective cohort study included 89 patients who initially presented with OMG and were followed up for at least 2 years. The primary outcome was conversion to GMG during follow-up. The investigated predictors included demographic variables, initial ocular manifestations, acetylcholine receptor antibody (AChR-Ab) status and titer, repetitive nerve stimulation test (RNST) findings, thymic abnormalities, and immunosuppressive treatment. Kaplan–Meier analyses and Cox proportional-hazards models were used to evaluate the GMG-free survival rate and risk factors for conversion.
Results
During follow-up, 10 patients (11.2%) progressed to GMG, with this conversion occurring within 2 years in 8 patients (9.0%). All converters were AChR-Ab positive. AChR-Ab positivity, RNST positivity, thymic abnormality, and thymoma were associated with GMG conversion in univariable analyses. RNST positivity in any tested muscle (hazard ratio [HR] = 12.66, 95% confidence interval [CI] = 2.68–59.76, p = 0.001) and thymoma (HR = 10.67, 95% CI = 3.06–37.27, p < 0.001) was associated with generalization. These associations persisted in the restricted multivariable Cox model.
Conclusions
The rate of GMG conversion was relatively low in this South Korean OMG cohort, and most conversions occurred within 2 years. The presence of AChR-Ab positivity, RNST abnormality, or thymoma may characterize high-risk patients who require closer monitoring during the early disease course.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Konkuk University, Chungju-si 27478, Republic of Korea.
- Department of Ophthalmology, Konkuk University Medical Center, Seoul 05030, Republic of Korea.
- Research Institute of Medical Science, Konkuk University, Seoul 05029, Republic of Korea.
- Department of Neurology, Konkuk University Medical Center, Seoul 05030, Republic of Korea.
ORCID-Profile: Hyun Jin Shin, Jeeyoung Oh
Förderung
- National Research Foundation of Korea
Zitieren
APA
Shin, H. J., Kwon, C., & Oh, J. (2026). Acetylcholine Receptor Antibody Positivity, RNST Abnormality, and Thymoma Predict Generalization in Ocular Myasthenia Gravis: A South Korean Cohort Study. Antibodies, 15(4), 73. https://doi.org/10.3390/antib15040073
Vancouver
Shin HJ, Kwon C, Oh J. Acetylcholine Receptor Antibody Positivity, RNST Abnormality, and Thymoma Predict Generalization in Ocular Myasthenia Gravis: A South Korean Cohort Study. Antibodies. 2026;15(4):73. doi:10.3390/antib15040073
BibTeX
@article{Shin2026,
author = {Shin, Hyun Jin and Kwon, Chaerin and Oh, Jeeyoung},
title = {Acetylcholine Receptor Antibody Positivity, RNST Abnormality, and Thymoma Predict Generalization in Ocular Myasthenia Gravis: A South Korean Cohort Study},
journal = {Antibodies},
year = {2026},
volume = {15},
number = {4},
pages = {73},
doi = {10.3390/antib15040073}
}
EUVIMED